CClinicalTrials.gg
Status unknownNCT01602133ECLIPSEUpdated Oct 25, 2012

Assessment of Ultrasound-guided Inserted Peripheral Intravenous Catheter

An interventional study of peripheral venous puncture in Venous Puncture, sponsored by Prodimed SAS. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-10-25.

Sponsored by Prodimed SAS · Not applicable and Interventional

The sponsor has not verified this record recently (last verified Oct 2012), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Evaluate the safety and efficacy of an an ultrasound-guided inserted peripheral intravenous catheter during a period of seven days.

02

Conditions studied

  • Venous Puncture

Keywords

  • venous puncture
  • seldinger technique
  • ultrasound guidance
03

In context

Lead sponsor

This is the only study on the registry with Prodimed SAS as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Hospitalized patients with need of an intravenous therapy on peripheral line
  • Unsuccessful attempts at establishing a peripheral intravenous line by nurse
  • Age over 18 YO
  • Written informed consent obtained

Exclusion criteria

Exclusion Criteria:

  • pregnant woman
  • local contra-indication for venous puncture
  • unconscious patient
  • need of intravenous therapy requiring central line
05

Study design

Phase
Not applicable
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
29 participants (estimated)

Study arms

  • Experimental
    one intervention arm

    Procedure: peripheral venous puncture

Interventions

  • Procedureperipheral venous puncture

    Ultrasound imaging of the arm is performed. If a suitable vein is identified, a percutaneous puncture is performed under ultrasound guidance. Then, an intravenous catheter is inserted according Seldinger method.

06

What researchers measure

Primary outcomes

  1. length of use of the catheter measured in number of days

    Time frame: seven days

Secondary outcomes

  1. adverse event during the period of use of the catheter

    extravasation and/or catheter removal before the end of the treatment and/or local complications (bleeding, neurologic trouble, venous thrombosis..)

    Time frame: seven days

07

Study locations

1 of 1 sites recruiting
  • Centre Hospitalier Sud Francilien
    Corbeil-essonnes, 91 100, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01602133
Lead sponsor
Prodimed SAS
Responsible party
Sponsor
First posted
May 18, 2012
Start date
Jun 2012
Primary completion
Jun 2014 (estimated)
Completion
Jun 2014 (estimated)
Last update
Oct 25, 2012

Study contacts

pascal meyer, MD
Contact
pas.meyer@yahoo.fr
Pascal Meyer, MD
principal investigator · Centre Hospitalier Sud Francilien- Corbeil- France

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion